Read the Latest News

TMD and Burning Mouth Syndrome

A study in the International Journal of Dental Research reporting the latest update on Burning Mouth Syndrome (BMS) noted two thirds of BMS patients also had Temporomandibular Disorders (TMD).

Stem Cell Study of Jaw Development Could Offer Insight Into Craniofacial Flaws

Scientists in the USC Stem Cell laboratory of Gage Crump have revealed how key genes guide the development of the jaw in zebrafish. These findings may offer clues for understanding craniofacial anomalies in human patients, who sometimes carry a mutation in equivalent genes.

Pain in Your Head Hurts More Than Elsewhere in the Body

Terrie Cowley, Co-Founder and President of The TMJ Association, often remarks that patients tell her that the pain they feel in their jaws is worse than pain elsewhere in the body.

2018 NIDCR and Hill Visits

On February 26, TMJA staff participated in the Friends of the National Institute of Dental and Craniofacial Research (NIDCR) Patient Advocacy Council (PAC), an umbrella group comprising non-profit organizations that work together to advance dental, oral,

Hyperreactive Brain Network May Be Cause of Chronic Pain in Fibromyalgia, Study Suggests

Fibromyalgia is one of the overlapping pain conditions with TMD. This article appeared in Fibromyalgia News Today on January 15, 2018. A new study suggests a hyperreactive brain network may be the underlying cause of chronic pain in fibromyalgia.

Good News...Exercise Improves Disc Displacement

  • Jul 27, 2017

A recent study conducted at the Tokyo Medical and Dental University found that therapeutic exercise brings earlier recovery of jaw function compared with splints!

Randomized Clinical Trial of Treatment for TMJ Disc Displacement

Abstract:

Of the various conservative treatment modalities available for temporomandibular disorders, we believe that therapeutic exercise has a good prognosis, especially for anterior disc displacement without reduction. Since its effectiveness has not been extensively evaluated, we conducted a comparative study to verify the hypothesis that treatment efficacy would not differ for exercise and occlusal splints. Fifty-two individuals with anterior disc displacement without reduction were randomly assigned to a splint or a joint mobilization self-exercise treatment group. Four outcome variables were evaluated: (i) maximum mouth-opening range without and (ii) with pain, (iii) current maximum daily pain intensity, and (iv) limitation of daily functions. All outcome variables significantly improved after 8 weeks of treatment in both groups. In particular, the mouth opening range increased more in the exercise group than in the splint group. This result demonstrates that therapeutic exercise brings earlier recovery of jaw function compared with splints.

Treatment Procedures:

All participants received a verbal explanation of their pathological conditions regarding jaw function based on x-ray and MRI findings, and a general self-care protocol such as good posture, soft diet, teeth apart, etc. 

Participants in the splint group wore a maxillary stabilization appliance while sleeping at night. The splint was 1.5-mm-thick hard, clear acrylic sheet that was vacuum-adapted to the maxillary cast. The splint was adjusted to ensure occlusal contact of all mandibular teeth in centric relation and mandibular canine guidance in eccentric movement.

In the exercise group, participants performed manual jaw-opening exercises by themselves, according to the following protocol: As a warm-up, the individual repeated small mouth-opening and closing movements several times. Then, the individual placed his/her fingertips on the edge of the mandibular anterior teeth and slowly pulled the mandible down until pain occurred on the TMJ-affected side. This mouth-opening position was held for 30 sec. Three cycles of this stretching movement were defined as a single set. The participant performed 4 sets per day, one after each meal and one while bathing.

All participants in both groups were prescribed a non-steroidal anti-inflammatory drug (Amfenac sodiu, Fenazox, Meiji Sika Co., Tokyo, Japan; 150 mg) 3 times every day, and were followed up at 4 and 8 weeks after the start of treatment. No significant adverse effect was reported resulting from either treatment.

TMJ Disorders

Comments:

Login or Register to add Comment

In Treating TMJ

To view or order a free booklet about TMJ Disorders, visit the National Institutes of Health website.

U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES
National Institutes of Health
National Institute of Dental and Craniofacial Research
Office of Research on Women's Health